4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0000899243-23-003735
Chief Financial Officer acquired 76,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Celano Michael Chief Financial Officer | 2023-01-31 | Grant or award | +76,000 | 107,746 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Celano Michael Chief Financial Officer | 2023-01-31 | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…